r.mcalister
TL3 Regular · Glasgow, UK
Retired process engineer. Interested in variability: between batches, between people, between weeks.
Joined 30 September 2024 · last posted 6d
130 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #83 · Practice › Interactions · 22 Jul 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #59 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 1 like The arithmetic in post #57 is right; the assumption feeding it is the part to check. Detection wavelength is one of those subjects where the general answer and the…
-
Seven-day rolling means and why weekly readings mislead Replied, post #82 · Outcomes › Progress reports · 22 Jul 2026 · 2 likes Post #79 answers the question as asked. The question underneath it is different. If you are new and reading this thread for the answer to seven-day rolling: the answer…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #14 · Compounds › Oral incretins · 21 Jul 2026 · 8 likes Answering the question post #10 raises rather than the one it answers. The gastrointestinal tolerability profile of the oral formulation is broadly similar in character…
-
Seven-day rolling means and why weekly readings mislead Replied, post #61 · Outcomes › Progress reports · 19 Jul 2026 · 21 likes Marking my place. If it changes for me I will come back and say so.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #41 · Access › Insurance & coverage · 18 Jul 2026 · 19 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #54 · Clinical › Comorbidities · 13 Jul 2026 · 3 likes Worth separating two things that post #50 runs together. PCOS and metabolic overlap is a good example of a question where the honest answer is boring and the…
-
How to ask a question when you cannot say why you are asking it Replied, post #32 · Start Here › How to Ask · 6 Jul 2026 · 30 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #19 · Compounds › Secretagogues & GH axis · 2 Jul 2026 · 30 likes Post #16 answers the question as asked. The question underneath it is different. On analysis: these are short peptides and generally straightforward…
-
Packaging that arrived damaged: documenting it properly Replied, post #34 · Sourcing › Logistics · 1 Jul 2026 · 31 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
Pages past their review date, listed — does this still hold? Replied, post #24 · Meta › Wiki maintenance · 24 Jun 2026 · 1 like Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue.
-
Does dual agonism explain the effect size, or is it dose? Replied, post #36 · Compounds › Tirzepatide · 14 Jun 2026 · 31 likes Answering the dual agonism question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
Revisiting: The best-written scientific paper you have read Replied, post #27 · Lounge › Off topic · 12 Jun 2026 · 2 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors.
-
CJC-1295 with and without DAC: what the modification does Replied, post #76 · Compounds › Secretagogues & GH axis · 6 Jun 2026 · 8 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #20 · Compounds › Secretagogues & GH axis · 1 Jun 2026 · 1 like The arithmetic in post #19 is right; the assumption feeding it is the part to check. I would call the community position on secretagogues and glucose tolerance likely…
-
Prescription requirements and telehealth models — a second dataset Replied, post #49 · Sourcing › Regulatory · 1 Jun 2026 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #85 · Sourcing › Logistics · 30 May 2026 · 11 likes Where I part company with post #83, and it is a narrow parting. Regional stock shortens the exposure window more than any packing improvement and is the practical…
-
Splitting an overlong document into two Replied, post #22 · Documentation › Wiki requests · 29 May 2026 · 1 like What would change my mind on splitting an overlong document is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I…
-
What to include when your question involves a chromatogram — one year on Replied, post #13 · Start Here › How to Ask · 23 May 2026 · 3 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context. It is…
-
Transporting a vial for a weekend away — a second dataset Replied, post #51 · Practice › Storage & stability · 12 May 2026 · 1 like Practical experience of Transporting a vial, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #110 · Practice › Interactions · 3 May 2026 · 28 likes This follows post #109 rather than contradicting it. A note on how anaesthesia and elective surgery gets discussed rather than on anaesthesia and elective surgery…
-
Research-use-only status: what it means legally and practically Replied, post #31 · Compounds › Other compounds · 22 Apr 2026 · 5 likes The arithmetic in post #28 is right; the assumption feeding it is the part to check. Answering the research-use-only status question as asked, then the question I think…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #3 · Outcomes › Body composition · 19 Apr 2026 · 0 likes Picking up post #2: that is the part I would want checked first. DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is…
-
List price versus negotiated price versus what you pay Replied, post #116 · Access › Pricing · 17 Apr 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #11 · Practice › Reconstitution · 17 Apr 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
List price versus negotiated price versus what you pay Replied, post #100 · Access › Pricing · 16 Apr 2026 · 0 likes An observation about list price versus negotiated price that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful…
-
Spike-and-recover accuracy for a peptide assay Replied, post #35 · Analytics › Method validation · 8 Apr 2026 · 21 likes I read post #31 twice before replying, because I had assumed the opposite. Validation is compound-specific and matrix-specific. A method validated for one peptide is a…
-
How to ask about something you suspect is a bad idea Replied, post #69 · Start Here › How to Ask · 25 Mar 2026 · 3 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #75 · Practice › Reconstitution · 25 Mar 2026 · 0 likes A definition problem is doing most of the work in this Foaming during reconstitution discussion. Once the term is pinned down I suspect the disagreement mostly goes…
-
Grapefruit: why this class is not the class that cares Replied, post #76 · Practice › Interactions · 24 Mar 2026 · 29 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
A plateau that disappeared when I changed how I measured Replied, post #26 · Outcomes › Progress reports · 24 Mar 2026 · 32 likes The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence.
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #50 · Research Methods › N-of-1 designs · 28 Feb 2026 · 0 likes It does not tell you about anybody else, which is why aggregating these accounts does not produce evidence of the kind people want it to. That is the shape of it. The…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #96 · Documentation › Wiki requests · 18 Feb 2026 · 6 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. Take it as a starting point and not as a…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #4 · Practice › Dosing & titration · 15 Feb 2026 · 28 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #20 · Analytics › Mass spectrometry · 12 Feb 2026 · 1 like The reason mass error in ppm is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #31 · Practice › Reconstitution · 11 Feb 2026 · 20 likes Bacteriostatic water contains benzyl alcohol; sterile water for injection does not. The difference matters when a container will be entered repeatedly over days and…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #26 · Outcomes › Progress reports · 9 Feb 2026 · 21 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding. I would put a moderate confidence on that and no more.
-
Constipation management, with a dietitian's contribution Replied, post #25 · Practice › Side effects · 1 Feb 2026 · 9 likes Building on post #22 rather than restating it. Two questions I would want answered before drawing anything from the constipation management data above: how were the…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #31 · Sourcing › Logistics · 1 Feb 2026 · 26 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Manufacturer assistance programmes and their eligibility rules Replied, post #3 · Access › Pricing · 30 Jan 2026 · 16 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion. I have separated what I observed from what I concluded, which does…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #26 · Research Methods › N-of-1 designs · 30 Jan 2026 · 0 likes The version of Pre-registering a personal experiment that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #106 · Clinical › Special populations · 26 Jan 2026 · 13 likes Answering the question post #102 raises rather than the one it answers. Extrapolating a point estimate to somebody well outside the enrolled range should be described…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #24 · Compounds › Oral incretins · 15 Jan 2026 · 4 likes Post #22 describes the usual case. This is about the unusual one. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #120 · Practice › Side effects · 30 Dec 2025 · 13 likes Useful. I have added it to my own notes with the date on it.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #25 · Sourcing › Red flags · 24 Dec 2025 · 3 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #23 · Sourcing › Regulatory · 8 Dec 2025 · 4 likes That is consistent with mine, for whatever one more account is worth.
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #4 · Practice › Reconstitution · 4 Dec 2025 · 24 likes Taking post #3 at face value and following it one step further. Reconstitution volumes is well covered in the tag pages, and the older discussions are better than the…
-
Robustness: the parameters worth deliberately varying Replied, post #27 · Analytics › Method validation · 28 Nov 2025 · 0 likes Answering the question post #25 raises rather than the one it answers. If someone has run robustness properly I would rather read that than my own reconstruction of it.…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #54 · Sourcing › Regulatory · 28 Nov 2025 · 23 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
-
Availability by country, dated, with primary sources Replied, post #79 · Access › International · 28 Nov 2025 · 14 likes On availability, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #64 · Analytics › Home & field testing · 27 Nov 2025 · 0 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide. Happy…
-
Whether protein timing matters at a large deficit Replied, post #4 · Nutrition & Training › Protein & intake · 22 Nov 2025 · 0 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #51 · Analytics › Home & field testing · 11 Nov 2025 · 27 likes I had written a reply contradicting post #47 and deleted it. Here is what survived. Nothing available at home distinguishes a correct sequence from a closely related…
-
Absence of evidence and evidence of absence Replied, post #4 · Research Methods › Statistics · 2 Nov 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Citation sweep results: how many references did not say what was claimed Replied, post #2 · Meta › Wiki maintenance · 30 Oct 2025 · 0 likes The reason citation sweep results is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
-
Thyroid function tests during substantial weight change Replied, post #112 · Clinical › Bloodwork · 28 Oct 2025 · 30 likes Post #111 put the caveat in the right place and I want to underline it. Small correction to my own earlier position on thyroid function tests during substantial. I had…
-
What pooling buys you and what it destroys Replied, post #48 · Evidence › Meta-analyses · 22 Oct 2025 · 1 like Distinguishing three things in the pooling buys discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #103 · Start Here › Welcome · 22 Oct 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
A 40-week log with the measurement method stated Replied, post #8 · Outcomes › Progress reports · 13 Oct 2025 · 0 likes Where I part company with post #4, and it is a narrow parting. Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more…
-
Specification in the result column: why that is a meaningful error Replied, post #57 · Analytics › COA interpretation · 12 Oct 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Revisiting: German, French and Dutch differences, compared Replied, post #84 · Regional › European Union · 9 Oct 2025 · 1 like On post #82 — agreed on the reasoning, with one qualification. An update on my earlier German post: the pattern held for another six weeks and then stopped, which I did…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #42 · Practice › Storage & stability · 17 Sep 2025 · 23 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #36 · Analytics › COA interpretation · 15 Sep 2025 · 0 likes Post #34 put the caveat in the right place and I want to underline it. A certificate is a statement by its issuer that a defined test was performed on a defined lot and…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #123 · Practice › Reconstitution · 11 Sep 2025 · 14 likes This follows post #120 rather than contradicting it. What I would tell a new member reading about 10 mg vial reconstituted three for the first time: the confident posts…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #42 · Data & Tools › Datasets · 8 Sep 2025 · 11 likes Picking up post #39: that is the part I would want checked first. On Aggregated purity results across four the community has more anecdote than the confidence in this…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #20 · Evidence › Journal club · 6 Sep 2025 · 0 likes No notes. Posting so the count is not one.
-
Which panel is worth repeating and which is worth ignoring Replied, post #103 · Clinical › Bloodwork · 5 Sep 2025 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #8 · Data & Tools › Calculators · 28 Aug 2025 · 6 likes Post #5 is the version of this I will quote in future. One addition. Maintaining a calculator means checking the arithmetic against hand-worked cases at each review,…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #15 · Practice › Side effects · 25 Aug 2025 · 15 likes The reason nausea timeline keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Asking about a compound your prescriber has not heard of Replied, post #123 · Clinical › Prescriber conversations · 12 Aug 2025 · 6 likes Picking up post #122: that is the part I would want checked first. A question phrased as "what would you want to see before considering X" is answerable and is not a…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #102 · Compounds › Semaglutide · 4 Aug 2025 · 4 likes Where I part company with post #98, and it is a narrow parting. On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #100 · Compounds › Semaglutide · 3 Aug 2025 · 0 likes I read post #96 twice before replying, because I had assumed the opposite. Adding a reference point for Semaglutide half-life. Mine is a single case, collected without…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #46 · Practice › Dosing & titration · 2 Aug 2025 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #23 · Compounds › Oral incretins · 1 Aug 2025 · 0 likes Post #19 describes the usual case. This is about the unusual one. On variability: the between-person spread in exposure for oral semaglutide is wide enough that two…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #20 · Compounds › Secretagogues & GH axis · 29 Jul 2025 · 11 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Are there stupid questions here? A staff answer, at length Replied, post #5 · marked as the solution · Start Here › Welcome · 22 Jul 2025 · 8 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Canadian access and provincial variation — one year on Replied, post #5 · Regional › North America · 18 Jul 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #98 · Practice › Reconstitution · 10 Jul 2025 · 11 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
What this community means by "a source", in practical terms Replied, post #23 · Start Here › Welcome · 3 Jul 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #13 · Compounds › Semaglutide · 1 Jul 2025 · 11 likes Worth separating two things that post #11 runs together. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and…
-
A comparison of home results against a laboratory result on the same vial Replied, post #8 · Analytics › Home & field testing · 24 Jun 2025 · 25 likes Where I part company with post #7, and it is a narrow parting. Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution that…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #71 · Practice › Storage & stability · 24 Jun 2025 · 26 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The claim is…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #16 · Compounds › Secretagogues & GH axis · 17 Jun 2025 · 4 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Coming back to: Getting a referral rather than a refusal Replied, post #48 · Clinical › Prescriber conversations · 9 Jun 2025 · 0 likes Where I part company with post #46, and it is a narrow parting. Getting a referral: I have looked for the primary source twice and failed twice. Either it does not…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #5 · Pharmacology › Receptor biology · 8 Jun 2025 · 20 likes Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
-
Half-life, steady state, and accumulation worked through Replied, post #80 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 0 likes Terminal half-life estimated from a short sampling window underestimates the true value. That is a common source of discrepant figures between sources. Adding this to…
-
Specification in the result column: why that is a meaningful error Replied, post #3 · Analytics › COA interpretation · 25 May 2025 · 2 likes A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing.…
-
One lot is one lot: when a report becomes a pattern Replied, post #3 · Sourcing › Vendor reports · 25 May 2025 · 0 likes Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report. For what it is worth,…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #86 · Outcomes › Body composition · 23 May 2025 · 9 likes This settles it for me, at least until somebody posts a reason it should not.
-
Publishing an inconvenient result: a case study Replied, post #23 · Sourcing › Independent verification · 22 May 2025 · 31 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #65 · Outcomes › Body composition · 19 May 2025 · 21 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #64 · Compounds › Secretagogues & GH axis · 17 May 2025 · 28 likes Distinguishing three things in the Tesamorelin discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Subcutaneous absorption kinetics and site differences Replied, post #3 · Pharmacology › Pharmacokinetics · 15 May 2025 · 12 likes Thank you for the correction. I would rather find out here than later.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #36 · Clinical › Comorbidities · 9 May 2025 · 3 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #4 · Clinical › Special populations · 2 May 2025 · 0 likes I read post #2 twice before replying, because I had assumed the opposite. A note on how History of disordered eating gets discussed rather than on History of disordered…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #81 · Access › Pricing · 28 Apr 2025 · 0 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #31 · Data & Tools › Calculators · 24 Apr 2025 · 16 likes Everything in post #27 holds. The case it does not cover is the one I have. Dose equivalence calculator: compounds have different potencies. The calculator is provided…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #59 · Evidence › Journal club · 20 Apr 2025 · 7 likes This is the answer, and the reason it is the answer is the more useful part.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #65 · Compounds › Tirzepatide · 20 Apr 2025 · 31 likes Post #63 describes the usual case. This is about the unusual one. An honest declaration on tirzepatide in type 2 diabetes: I have a prior here and it is strong enough…
-
A report I filed that turned out to be wrong, and the correction Replied, post #17 · Sourcing › Vendor reports · 17 Apr 2025 · 1 like Report the certificate figure alongside the independent one. The comparison is the point and it is the part most often omitted. If it helps: the failure mode here is…
-
Micronutrient status when intake falls substantially Started this topic · Clinical › Bloodwork · 14 Apr 2025 · 6 likes On the subject in the title: Micronutrient status when intake falls substantially Working notes rather than a conclusion. Posting a small dataset on micronutrient…
-
Carryover and the ghost peak from last week's standard Replied, post #77 · Analytics › HPLC & UHPLC · 10 Apr 2025 · 8 likes On post #73 — agreed on the reasoning, with one qualification. Where the baseline is drawn is the least documented and most consequential choice in the whole…
-
Retatrutide dose escalation in the published trials Replied, post #81 · Compounds › Retatrutide · 2 Apr 2025 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #137 · Analytics › COA interpretation · 29 Mar 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
When to suspect the method rather than the sample Replied, post #98 · Analytics › Method validation · 16 Mar 2025 · 9 likes A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document describing it. Transfer is where a great many…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #73 · Evidence › Meta-analyses · 8 Feb 2025 · 15 likes Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it requires cooperation rather than a search.
-
Scheduled maintenance and what will be unavailable Replied, post #34 · Meta › Announcements · 5 Feb 2025 · 8 likes I read post #30 twice before replying, because I had assumed the opposite. Thank you for announcing it in advance rather than after. The number of places that do the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #11 · Practice › Reconstitution · 3 Feb 2025 · 28 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Protein density versus volume when you cannot eat much Replied, post #35 · Nutrition & Training › Protein & intake · 29 Jan 2025 · 0 likes Where I part company with post #34, and it is a narrow parting. What tends to work is front-loading the day, prioritising density over volume, and treating it as a…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 17 Jan 2025 · 32 likes Post #10 and I disagree about the size of the effect, not about the direction. Practical experience of Historical amylin analogues, offered as one case with the…
-
Fixed versus detachable needles: the trade-offs Replied, post #90 · Devices › Syringes & needles · 4 Jan 2025 · 30 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Isotonicity and what happens when you get it wrong Replied, post #16 · Pharmacology › Formulation chemistry · 3 Jan 2025 · 6 likes Light sensitivity varies enormously between peptides depending on the residues present. Tryptophan-containing sequences are the ones where it matters most.
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #13 · Compounds › Oral incretins · 1 Jan 2025 · 18 likes The practical argument for an oral is adherence, and the published adherence data is less flattering than the argument. Daily dosing with fasting requirements is not…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #87 · Access › Insurance & coverage · 25 Dec 2024 · 21 likes Answering the Step therapy requirements question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
-
Body image changing more slowly than the body Replied, post #122 · Wellbeing › Mental health · 24 Dec 2024 · 0 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #25 · Compounds › Semaglutide · 20 Dec 2024 · 15 likes Thank you for taking the time. That was more work than a reply usually is.
-
Body image changing more slowly than the body Replied, post #36 · Wellbeing › Mental health · 15 Dec 2024 · 8 likes Post #32 describes the usual case. This is about the unusual one. On body image: the maintained page in the documentation commons covers the general case with citations…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #57 · Nutrition & Training › Protein & intake · 14 Dec 2024 · 0 likes Post #55 and I disagree about the size of the effect, not about the direction. Where I have landed on Meeting a protein target, having got it wrong once in public: the…
-
Why "any advice?" is the least effective ending for a post Replied, post #76 · Start Here › How to Ask · 26 Nov 2024 · 1 like Sensible. I would want the same detail before I acted on it either.
-
Transit times by route, from a logged dataset — the long version Replied, post #29 · Sourcing › Logistics · 13 Nov 2024 · 7 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #47 · Clinical › Prescriber conversations · 10 Nov 2024 · 1 like Post #44 is right about the mechanism and I think understates the practical bit. A question phrased as "what would you want to see before considering X" is answerable…
-
Time to steady state after a dose increase Replied, post #148 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Confirming post #147 from a second method, which matters more than confirming it from a second person. Metabolism for peptide drugs is proteolytic rather than hepatic…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #108 · Analytics › COA interpretation · 6 Nov 2024 · 0 likes Where I part company with post #106, and it is a narrow parting. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #7 · Practice › Interactions · 6 Nov 2024 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Two questions I would want answered before drawing anything from the Anaesthesia…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #18 · Clinical › Prescriber conversations · 30 Oct 2024 · 27 likes This is the sort of exchange that makes the archive worth searching.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #14 · Practice › Interactions · 6 Oct 2024 · 3 likes Marking my place. If it changes for me I will come back and say so.
-
Promotion criteria, and the one that stops most nominations Replied, post #76 · Documentation › Doc review · 3 Oct 2024 · 9 likes The question underneath promotion criteria is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #27 · Sourcing › Independent verification · 31 Aug 2024 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Promotion criteria, and the one that stops most nominations Replied, post #43 · Documentation › Doc review · 21 Aug 2024 · 11 likes Post #41 put the caveat in the right place and I want to underline it. Adding what did not work for me on promotion criteria, since the failures never get written up…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #79 · Compounds › Retatrutide · 21 Jul 2024 · 0 likes Reading this Retatrutide dose escalation thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.